Concepedia

Alison Nankervis

AN

Statistics

Publications

47

Citations

5.6K

H-Index

27

Active since

1982

Affiliations

The University of Melbourne(Current)

The Royal Melbourne Hospital

Royal Women's Hospital

St Vincent's Hospital Melbourne

Medical University of South Carolina

Alison Nankervis is an author at The University of Melbourne specializing in diabetes mellitus, medicine, and endocrinology.

ORCID

Publications per year

1982–2022

47

Publications

47

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 3K citations · Full text

, , +14

Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial

Hertzel C. Gerstein, Helen M. Colhoun, Gilles R. Dagenais et al. · The Lancet · 2019 · 629 citations · Full text

, , +15

Cardiovascular and metabolic effects of metformin in patients with type 1 diabetes (REMOVAL): a double-blind, randomised, placebo-controlled trial

John R. Petrie, Nish Chaturvedi, Ian Ford et al. · The Lancet Diabetes & Endocrinology · 2017 · 347 citations · Full text

, , +14

ADIPS Consensus Guidelines for the Testing and Diagnosis of Gestational Diabetes Mellitus in Australia

Alison Nankervis, David McIntyre, Robert G. Moses et al. · 2014 · 100 citations

, , +14

Effectiveness and side effects of thiazolidinediones for type 2 diabetes: real‐life experience from a tertiary hospital

Zanariah Hussein, John M. Wentworth, Alison Nankervis et al. · The Medical Journal of Australia · 2004 · 90 citations

, , +17

1–5 of 47